medline.ch Gynäkologie Mammae

	Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HRâ€‰+â€‰/HER2- advanced breast cancer after CDK4/6 inhibitor. Breast Cancer Res Treat Jara P, Ariant M, Jiménez R, Bringas M, Herrero B, Echavarría I, Jerez Y, López-Tarruella S, Márquez-Rodas I, Del Monte-Millán M, Massarrah T, de la Peña FA, Martín M. PMID: 41348333 [PubMed - indexed for MEDLINE]
	Advancing breast cancer treatment through dual targeting CAR T cell therapy. Discov Oncol Sheikh M, Madia D, Telrandhe UB, Bagga H, Deshmukh A. PMID: 41348261 [PubMed - as supplied by publisher]
	Factors associated with receipt of surveillance breast MRI among racially and ethnically diverse women with operable breast cancer. Breast Cancer Res Treat Kakani P, Ro V, McGuinness JE, Michel A, Crew KD. PMID: 41348256 [PubMed - indexed for MEDLINE]
	Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer. Breast Cancer Res Treat Laperche-Santos D, Assad-Suzuki D, Resende H, Moura FC, Oliveira SCS, Shimada AK, Arakelian R, Galvão ALZ, de Souza BSW, Custodio AGC, de Andrade MCFM, Bittencourt YCRB, Magalhães MCF, de Pádua Souza C, Paiva CE, Signorini PA, Pereira DJ, Nogueira-Rodrigues A, Rosa DD, Barroso-Sousa R. PMID: 41348250 [PubMed - indexed for MEDLINE]
	Comment on "Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis". Breast Cancer Res Treat Dedeepya SD, Goel V, Desai NN. PMID: 41348236 [PubMed - indexed for MEDLINE]
	Dynamic Contrast-enhanced MRI for Evaluating Breast Cancer Chemotherapy Response Using Conditional Generative Adversarial Networks. Radiol Imaging Cancer Arledge CA, Zhao AH, Topaloglu U, Zhao D. PMID: 41347917 [PubMed - indexed for MEDLINE]
	Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain. Int J Cancer Pino-Rosón C, Ávila-Arroyo S, Parra-Blázquez D, Soto Zabalgogeazcoa MJ, Moñino D, López-González R, Sevilla-Hernández C, González-Blázquez C, Martín M, Aragonés N. PMID: 41347779 [PubMed - as supplied by publisher]
	Complications and Satisfaction After Adolescent Breast Reduction for Juvenile Macromastia: Systematic Review and Meta-analysis. Plast Reconstr Surg Glob Open Bohler F, Noorani A, Chaiyasate K. PMID: 41346929 [PubMed]
	Assisted Breast Reconstruction With Biosynthetic Mesh and Implants: A Pilot Study. Plast Reconstr Surg Glob Open Cavalcante FP, Zerwes FP, Millen EC, Mattar A, Antonini M, Brenelli FP, Frasson AL, Bagnoli F, Garcia GN, da Costa Vieira RA. PMID: 41346927 [PubMed]
	Correction to Exploring the Metabolic Profiling and Anticancer Activities of Red Sea Sponges Echinodictyum asperum and Callyspongia siphonella against Human Breast Cancer Cells: A Comparative Study. ACS Omega Abuzahrah SS, Bakhsh T, Mekky RH, Elbehairi SEI, Juaid N. PMID: 41346862 [PubMed]
	Effectiveness of Regional Blocks for Postoperative Pain Control and Recovery in Breast Cancer Surgery in a Resource-Limited Setting: A Prospective Observational Study. Cureus Nellihela AP, Senevirathne RN, Bandaranayake V, Kerner V, Jayasena A, Karunanithy P, Rajapakshe KA, Weddagala S, Warnakula S, Senarathna M. PMID: 41346421 [PubMed]
	The impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer. Ann Med Ma Y, Wu S, Li X, Jiang Y, Xiao L, Wang Y, Sun T. PMID: 41346024 [PubMed - indexed for MEDLINE]
	Multiparametric MRI deep learning model based on dynamic Contrast-enhanced and apparent diffusion coefficient map enables accurate prediction of benign and malignant breast lesions. Cancer Imaging Luo C, Chen Y, Yan L, Wang C, Wang L, Luo R, Zhang Z, Wang R, Zhang F, Zhang Z, Yin Q, Zhang Y, Liu H, Wang D. PMID: 41345985 [PubMed - as supplied by publisher]
	Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results. NPJ Precis Oncol Moore-Palhares D, Alberico D, Chan AW, DiCenzo D, Sannachi L, Dasgupta A, Yip J, Pena MLA, Gandhi S, Pezo R, Eisen A, Jerzak KJ, Gonzalez CAC, Warner E, Wright FC, Look-Hong N, Roberts A, Sadeghi-Naini A, Curpen B, Skarpathiotakis M, Betel C, Kolios MC, Trudeau M, Czarnota GJ. PMID: 41345775 [PubMed]
	Tumor shrinkage patterns and optimal timing of response assessment during neoadjuvant therapy for breast cancer: a study based on multiparametric MRI. Cancer Imaging Wang J, Liu Y, Liu T, Li Y, Ma X, Zhao Y, Lu H. PMID: 41345717 [PubMed - as supplied by publisher]
	Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E. BMC Cancer Sperk E, Lemanski C, Neumaier C, Lauer J, Siefert V, Völker R, Lindner C, Niehoff P, Tallet AR, Racadot S, Petit A, Pazos M, Le-Blanc Onfroy M, Martin E, Reuter C, Hermann RM, Pohl F, Friedrichs K, Würschmidt F, Pigorsch S, Kolberg HC, Graf H, Brunner TB, Malter W, Park-Simon TW, Brucker C, Fleckenstein J, Petersen C, Tuschy B, Wilken EE, Büttner S, Sütterlin M, Flyger H, Wenz F. PMID: 41345599 [PubMed - as supplied by publisher]
	Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis ofÂ randomized controlled trials. J Chemother Hsiao SY, Lin WT, Lin CY, Chao CM, Weng TS. PMID: 41345476 [PubMed - as supplied by publisher]
	Night shift work and breast cancer: from etiopathology to precision risk analysis. NPJ Breast Cancer Vivarelli S, Formica T, Puliatti Y, Spatari G, Fenga C. PMID: 41345403 [PubMed - as supplied by publisher]
	Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion. NPJ Breast Cancer Iyengar NM, O'Shaughnessy JA, Moore HB, Hamilton E, Jhaveri KL, Ma CX, Tedesco K, Vasekar M, Donahue S, Rugo HS. PMID: 41345397 [PubMed - as supplied by publisher]
	Factors Influencing Time to Treatment Initiation for Breast Cancer in Ethiopia. Cancer Med Kibret AA, Jiang J, Woldetsadik ES, Tafese MD, Deressa BT, Liu C. PMID: 41345041 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 212566

Seite 1 von 10629

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung